Profil bibliographique

Swarupa G. Kulkarni

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

37Publications signalées

1028Citations signalées

3Affiliations récentes

Institutions déclarées

GlaxoSmithKline (United States)Novartis (United States)Tris Pharma (United States)

Domaines associés

Melanoma and MAPK PathwaysPharmacogenetics and Drug MetabolismDrug Transport and Resistance MechanismsCystic Fibrosis Research AdvancesDrug-Induced Hepatotoxicity and Protection

Publications récentes

Accès ouvert 2023 other

Data from GSK1120212 (JTP-74057) Is an Inhibitor of MEK Activity and Activation with Favorable Pharmacokinetic Properties for Sustained In Vivo Pathway Inhibition

Aidan G. Gilmartin, Maureen R. Bleam, Arthur Groy, Katherine G. Moss et autres

0 citations

Accès ouvert 2023 supplementary-materials

Supplementary Data from GSK1120212 (JTP-74057) Is an Inhibitor of MEK Activity and Activation with Favorable Pharmacokinetic Properties for Sustained In Vivo Pathway Inhibition

Aidan G. Gilmartin, Maureen R. Bleam, Arthur Groy, Katherine G. Moss et autres

0 citations

Accès ouvert 2023 other

Data from GSK1120212 (JTP-74057) Is an Inhibitor of MEK Activity and Activation with Favorable Pharmacokinetic Properties for Sustained In Vivo Pathway Inhibition

Aidan G. Gilmartin, Maureen R. Bleam, Arthur Groy, Katherine G. Moss et autres

0 citations

Accès ouvert 2023 supplementary-materials

Supplementary Data from GSK1120212 (JTP-74057) Is an Inhibitor of MEK Activity and Activation with Favorable Pharmacokinetic Properties for Sustained In Vivo Pathway Inhibition

Aidan G. Gilmartin, Maureen R. Bleam, Arthur Groy, Katherine G. Moss et autres

0 citations

2023 article

Establishing the Safe Space via Physiologically Based Biopharmaceutics Modeling. Case Study: Fevipiprant/QAW039

Alexandros Kourentas, Monika Gajewska, Wen Lin, Sundeep S. Dhareshwar et autres

13 citationsThe AAPS Journal

Accès ouvert 2022 dataset

CCDC 2190540: Experimental Crystal Structure Determination

Darren Le Grand, Martin Gosling, Urs Baettig, Parmjit Bahra et autres

0 citationsThe Cambridge Structural Database

Accès ouvert 2022 dataset

CCDC 2190539: Experimental Crystal Structure Determination

Darren Le Grand, Martin Gosling, Urs Baettig, Parmjit Bahra et autres

0 citationsThe Cambridge Structural Database

2021 article

Fevipiprant (QAW039) does not affect the pharmacokinetics of zidovudine, its glucuronide, and penicillin G via inhibition of UGT2B7 and/or OAT3

Swarupa G. Kulkarni, Birk Poller, Anton Drollmann, Bharti Shah et autres

1 citationPulmonary Pharmacology & Therapeutics

Accès ouvert 2021 article

Discovery of Icenticaftor (QBW251), a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator with Clinical Efficacy in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease

Darren Le Grand, Martin Gosling, Urs Baettig, Parmjit Bahra et autres

36 citationsJournal of Medicinal Chemistry

2021 article

The pharmacology of the prostaglandin D2 receptor 2 (DP2) receptor antagonist, fevipiprant

Christopher E. Brightling, Swarupa G. Kulkarni, Bart N. Lambrecht, David A. Sandham et autres

11 citationsPulmonary Pharmacology & Therapeutics

Accès ouvert 2021 article

Population Pharmacokinetic Analysis of Fevipiprant in Healthy Subjects and Asthma Patients using a Tukey’s g-and-h Distribution

Xinting Wang, Christian Bartels, Swarupa G. Kulkarni, Ramachandra Sangana et autres

0 citationsDrug Research

Accès ouvert 2021 article

Clinical Investigation of Metabolic and Renal Clearance Pathways Contributing to the Elimination of Fevipiprant Using Probenecid as Perpetrator

H. Weiss, Thomas Langenickel, Meredith Cain, Swarupa G. Kulkarni et autres

11 citationsDrug Metabolism and Disposition

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.